middle.news
How Will Biotron’s $2.5M Deal Unlock Next-Gen Anaesthetic Potential?
11:21am on Wednesday 15th of October, 2025 AEDT
•
Healthcare
Read Story
How Will Biotron’s $2.5M Deal Unlock Next-Gen Anaesthetic Potential?
11:21am on Wednesday 15th of October, 2025 AEDT
Key Points
Acquisition of Sedarex Limited with global patents for SedRx anaesthetic
SedRx shows superior safety and cognitive outcomes in clinical trials
FDA supports expedited 505(b)(2) regulatory pathway for SedRx
$2.5 million capital raise via $1 million placement and $1.5 million rights issue
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE